Published in Lancet on January 24, 2004
Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis (2006) 3.32
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet (2006) 2.86
Monitoring HIV treatment in developing countries. BMJ (2006) 1.13
Barriers to better care for people with AIDS in developing countries. BMJ (2004) 1.03
Promoting development and uptake of health innovations: The Nose to Tail Tool. F1000Res (2016) 0.75
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
An assessment of interactions between global health initiatives and country health systems. Lancet (2009) 10.53
Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet (2010) 7.07
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med (2003) 6.07
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA (2005) 5.39
International standards for tuberculosis care. Lancet Infect Dis (2006) 4.67
Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet (2004) 4.21
Increasing transparency in partnerships for health--introducing the Green Light Committee. Trop Med Int Health (2002) 3.59
Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis (2006) 3.32
Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science (2002) 2.65
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med (2004) 2.05
Examining the production costs of antiretroviral drugs. AIDS (2006) 1.97
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis (2013) 1.96
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Expanding tuberculosis case detection by screening household contacts. Public Health Rep (2005) 1.58
The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am (2002) 1.39
Jim Yong Kim--WHO HIV/AIDS Director. Interviewed Pam Das. Lancet Infect Dis (2005) 1.37
The "vertical-horizontal" debates: time for the pendulum to rest (in peace)? Bull World Health Organ (2007) 1.33
Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis (2007) 1.29
Scaling up treatment--why we can't wait. N Engl J Med (2005) 1.28
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Curr Opin Pulm Med (2010) 1.27
WHO and the future of disease control programmes. Lancet (2013) 1.21
Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ (2007) 1.19
Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis (2006) 1.13
The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. Bull World Health Organ (2007) 1.05
Scale up: meeting targets in global tuberculosis control. Lancet (2004) 1.04
Essential medicines pricing--reform needed. Lancet (2008) 1.00
Facing extensively drug-resistant tuberculosis--a hope and a challenge. N Engl J Med (2008) 1.00
A road map to control malaria, tuberculosis, and human immunodeficiency virus/AIDS. Arch Intern Med (2009) 0.99
What research is needed to stop TB? Introducing the TB Research Movement. PLoS Med (2011) 0.97
Improving prevention of mother-to-child transmission of HIV care and related services in eastern Rwanda. PLoS Med (2010) 0.97
Rebuttal: Evidence and uncertainties. Int J Tuberc Lung Dis (2002) 0.95
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother (2013) 0.93
Tuberculosis as a major global health problem in the 21st century: a WHO perspective. Semin Respir Crit Care Med (2004) 0.92
The Global Plan to Stop TB, 2006-2015. Int J Tuberc Lung Dis (2006) 0.88
Drug-resistant tuberculosis: latest advances. Lancet Respir Med (2013) 0.87
Setting new targets in the fight against tuberculosis. Nat Med (2013) 0.85
Venice Statement on global health initiatives and health systems. Lancet (2009) 0.85
From threat to reality: the real face of multidrug-resistant tuberculosis. Am J Respir Crit Care Med (2008) 0.82
Multidrug-resistant tuberculosis in Eastern Europe: still on the increase? Eur Respir J (2012) 0.79
Hurry up and wait? Accelerating access to the Three I's for HIV-TB. Int J Tuberc Lung Dis (2012) 0.78
HIV, infant feeding and implementation failure: advancing policies for women with HIV infection and attaining the Millennium Development Goals. Bull World Health Organ (2009) 0.78
Newsmaker interview. Jim Kim on why he took the top job at Dartmouth. Interview by Jon Cohen. Science (2009) 0.77
Here is diabetes in The Lancet's tuberculosis series! Lancet (2010) 0.75
WHO's HIV/AIDS strategy under the spotlight. Bull World Health Organ (2004) 0.75
Straight talk with...Jim Yong Kim. [Interview by Prashant Nair]. Nat Med (2008) 0.75
HIV/AIDS in the Eastern Mediterranean: a false immunity? East Mediterr Health J (2002) 0.75
Tuberculosis care and control. Bull World Health Organ (2006) 0.75
A lifelong battle against disease. US News World Rep (2007) 0.75
World Tuberculosis Day 2009: partnership for TB care. Indian J Med Res (2009) 0.75
Mario C Raviglione. Interview. Lancet (2006) 0.75
Dr LEE Jong-wook (1945-2006): a personal tribute. Bull World Health Organ (2006) 0.75